glp-1 mechanism of action Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and #obesity. receptor agonists and GLP-1 and glucose-dependent insulinotropic The Potential Role of GLP-1

In a dosing ranging study, 472 individuals who are overweight without diabetes were randomised and 72% completed 26 weeks of treatment

The mazdutide versus tirzepatide comparison is complicated by the fact that most mazdutide data comes from East Asian populations, which may respond differently to weight loss medications

Klotho is required for metabolic activity of fibroblast growth factor 21

Well cover both

Both Nirchi and Long point to things like nausea and constipation, particularly when starting the drugs or titrating up to a higher dose (but for them, the benefits have outweighed the downsides)

doi: 10.1001/jama.2021.1831